Dr Lal Pathlabs informs about schedule of analyst meet

04 Sep 2019

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting. 

The above information is a part of company’s filings submitted to BSE.

Related Dr. Lal Pathlabs Ltd. Links:

Dr Lal Pathlabs Share Price

2917.80 -14.85 (-0.51%) Apr 16, 18:01
1 Year Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 3060.20
Aster DM Healthcare 146.55
Narayana Hrudayalay 401.50
Dr Lal Pathlabs 2917.80
Metropolis Health. 2484.45
View more..
Sensex vs Dr Lal Pathlabs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback